Back to company

LICA PHARMACEUTICALS ApS: Financial statements 2015

CVR: 25332520

LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 312,007 and a net result of DKK -2,255,485 compared with DKK 3,869,932 the year before. That is an increase of 15.8% compared with the year before. Equity amounted to DKK 11,655,463. The solvency ratio was 99.2%.

Gross Profit
312,007 kr.
Profit/Loss
-2,255,485 kr.
Equity
11,655,463 kr.
Total Assets
11,744,229 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-312 t.-2.3 mio.11.7 mio.-
2014-269 t.3.9 mio.13.9 mio.-
2013-341 t.783 t.10 mio.-
2012468 t.296 t.953 t.9.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2015

LICA PHARMACEUTICALS ApS appoints new auditorDec 21, 2015

As of December 21, 2015, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of LICA PHARMACEUTICALS ApS.

Auditor steps down at LICA PHARMACEUTICALS ApSDec 21, 2015

As of December 21, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of LICA PHARMACEUTICALS ApS.

LICA PHARMACEUTICALS ApS: The 2014 annual report is outJun 1, 2015

LICA PHARMACEUTICALS ApS has published its annual report for 2014. Gross profit came to DKK 269,406, and the net result was DKK 3,869,932.

About LICA PHARMACEUTICALS ApS

LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.